Juntai Pharmaceutical Named 2024 Shandong Gazelle Enterprise

2025.01.10

Shandong Juntai Pharmaceutical Co., Ltd. has been recognized as a 2024 Shandong Province Gazelle Enterprise, marking another milestone in the company's development and commitment to technological innovation.

The recognition acknowledges Juntai Pharmaceutical's innovation capabilities, research and development efforts, and growth potential within the pharmaceutical and cosmetic ingredients industries.

As a company specializing in pharmaceutical intermediates, cosmetic active ingredients, and custom synthesis, Juntai Pharmaceutical continues to strengthen its technical expertise and manufacturing capabilities to support long-term development.

Provincial Recognition for Innovation and Growth

The Gazelle Enterprise designation recognizes high-growth companies that have moved beyond their early development stages and demonstrated strong potential through technological innovation, business development, and industry specialization.

In Shandong Province, the recognition program aims to support innovative enterprises with strong growth prospects and encourage technological advancement across regional industries.

Juntai Pharmaceutical's inclusion in the 2024 recognition list reflects the company's continued investment in research, process development, and industrial capabilities.

It also represents an important achievement in the company's efforts to build a competitive position in pharmaceutical and cosmetic ingredient manufacturing.

Strengthening Research and Development Capabilities

Research and development remain central to Juntai Pharmaceutical's business.

The company operates an approximately 1,500-square-meter R&D center in Jinan High-tech Industrial Development Zone, Shandong Province, focusing on small-molecule synthesis, chemical process development, analytical testing, and related technologies.

Its research activities cover multiple stages of chemical development, from laboratory-scale synthesis and process optimization to scale-up studies and manufacturing support.

Juntai Pharmaceutical also works with universities and research institutions to explore new synthetic approaches and improve existing manufacturing processes.

These collaborations help connect laboratory research with practical industrial applications and strengthen the company's ability to address technical challenges in chemical synthesis.

Supporting Pharmaceutical and Cosmetic Ingredient Development

Juntai Pharmaceutical has developed technical capabilities across pharmaceutical intermediates, cosmetic active ingredients, and custom synthesis services.

In the pharmaceutical sector, the company focuses on organic synthesis, intermediate development, process optimization, and customized chemical manufacturing projects.

For cosmetic ingredients, its research includes synthetic route development, impurity control, analytical evaluation, and manufacturing process improvement.

Supported by its research center and manufacturing facilities in Shandong Province, Juntai Pharmaceutical works to improve coordination between laboratory development and industrial production.

This integrated approach supports the development of chemical manufacturing processes and helps the company respond to the technical requirements of different B2B projects.

The 2024 Gazelle Enterprise recognition marks another step in the company's ongoing development within these specialized fields.

Continuing Investment in Technology and Manufacturing

Juntai Pharmaceutical regards technological innovation as an essential part of its long-term development.

Looking ahead, the company plans to continue strengthening its research capabilities, advancing chemical synthesis technologies, and improving manufacturing processes.

Further collaboration with academic and research institutions will remain an important part of its approach to technology development.

By building on its experience in chemical synthesis, process development, and industrial manufacturing, Juntai Pharmaceutical aims to support customers and partners across the pharmaceutical and personal care industries.

The recognition as a Shandong Province Gazelle Enterprise represents both an important achievement and a new stage in Juntai Pharmaceutical's continued development.

About Shandong Juntai Pharmaceutical

Shandong Juntai Pharmaceutical Co., Ltd. is a China-based company specializing in the research, development, and manufacturing of pharmaceutical intermediates, cosmetic active ingredients, and custom synthesis services.

With an R&D center in Jinan and manufacturing facilities in Shandong Province, the company combines chemical research, process development, analytical testing, and production capabilities to support domestic and international B2B customers.

Official Website: https://www.h2opharm.com